MedTrace Logo

Individually Tailored Training Prescriptions in Cancer Patients: The TOP Study

NCT02883699 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2020-03-31

No results posted yet for this study

Summary

The TOP Study is a two-stage study on individually tailored endurance and resistance training prescriptions for breast and prostate cancer patients after the end of primary therapy in order to optimize training effects.

Conditions

Interventions

BEHAVIORAL

Standard endurance training

Continuous vigorous training 2 x per week on a cycle ergometer

BEHAVIORAL

Polarized endurance training

Continuous moderate training 1 x per week and aerobic high intensity interval training (HIIT) 1 x per week on the cycle ergometer

BEHAVIORAL

Standard resistance training

Machine based hypertrophy training 2 x per week

BEHAVIORAL

Daily undulating periodization resistance training

Machine based daily undulating periodization resistance training 1 x per week

Sponsors & Collaborators

  • Friederike Rosenberger (University Hospital Heidelberg), Principal Investigator

    collaborator UNKNOWN

  • Dietmar Hopp Stiftung

    collaborator OTHER

  • University Hospital Heidelberg

    lead OTHER

Principal Investigators

  • Joachim Wiskemann, Dr. · Heidelberg University Hospital, National Center for Tumor Diseases, Division of Medical Oncology, Working Group Exercise Oncology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-01-31
Completion
2020-03-27

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02883699 on ClinicalTrials.gov